29.01.2010 • NewsHenkelprofits

Henkel Sees Drop in Sales and Earnings in 2009; Performance Still Better Than Expected

Henkel has announced that 2009 sales will decline by 3.5% to around €13.57 billion. The company said it expects adjusted earnings to fall to €1.91 per preferred share from €2.19 a share a year ago. However, the company concluded that the 2009 recession year has been "better than anticipated." The company has posted a strong business performance for Q4 2009, citing better-than-expected developments in their Laundry & Home Care and Adhesive Technologies business sectors. Adjusted return on sales (EBIT) further increased in the fourth quarter to 12.4%. The company is scheduled to release final figures on Feb. 25

Company

Henkel AG & Co. KGaA

Henkelstr. 67
40589 Düsseldorf
Germany

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.